cubebin has been researched along with scopolamine hydrobromide in 1 studies
| Studies (cubebin) | Trials (cubebin) | Recent Studies (post-2010) (cubebin) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 34 | 0 | 17 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | cubebin (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghumatkar, PJ; Laddha, KS; Mulik, MB; Nahire, MS; Parikh, AD; Sathaye, S; Somani, GS | 1 |
1 other study(ies) available for cubebin and scopolamine hydrobromide
| Article | Year |
|---|---|
Neuroprotective effect of Cubebin: A dibenzylbutyrolactone lignan on scopolamine-induced amnesia in mice.
Topics: Acetylcholinesterase; Amnesia; Animals; Brain; Cholinesterase Inhibitors; Furans; Humans; Lignans; Maze Learning; Mice; Molecular Docking Simulation; Neuroprotective Agents; Oxidative Stress; Scopolamine | 2017 |